stars 1 stars 2 stars 3

Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com

Website http://www.novalix.com
Revenue $90.9 million
Employees 331 (295 on RocketReach)
Founded 2002
Address 16, Rue d'ankara, Strasbourg, Grand Est 67000, FR
Technologies
Industry Biotechnology Research, Target based drug discovery, NMR, SPR, Graffinity, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Insourcing, Cryo-Electron Microscopy, Chemical development, Micro-Array Spr, Medicinal chemistry
Web Rank 5 Million
Keywords Drug Discovery, Biotech, Pharmaceutical, Preclinical, Drug Development, Scientific Research, Life Sciences, Clinical Trials, Biotechnology, Pharmaceutical Research, Drug Design, Medicinal Chemistry, Research And Development, Contract Research Organization, Cmo, Pharmaceutical Services, Clinical Research, Platform Technologies
Competitors Research Pharmaceutical Services, Labcorp, Charles River Laboratories, Medpace, WuXi AppTec, Evotec, Celerion, 上海润诺生物科技有限公司, Sygnature Discovery, The Chemistry Group +48 more (view full list)

NovAliX Questions

The NovAliX annual revenue was $90.9 million in 2026.

Denis Zeyer is the CEO of NovAliX.

295 people are employed at NovAliX.

NovAliX is based in Strasbourg, Grand Est.

Top NovAliX Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users